N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide
C25H25N5OS — CID 172571755
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide
N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide (PubChem CID 172571755) has the molecular formula C25H25N5OS and a molecular weight of 443.58 g/mol. Its IUPAC name is N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide.
Molecular Properties
| Compound Name | N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide |
|---|---|
| PubChem CID | 172571755 |
| Molecular Formula | C25H25N5OS |
| Molecular Weight | 443.58 g/mol |
| Exact Mass | 443.18 |
| IUPAC Name | N-[5-[1-(cyclopropylmethyl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrrolo[3,2-c]pyridin-4-yl]-2-methylphenyl]prop-2-enamide |
| SMILES | C=CC(=O)Nc1cc(-c2nc(Nc3ncc(C)s3)cc3c2ccn3CC2CC2)ccc1C |
| InChI | InChI=1S/C25H25N5OS/c1-4-23(31)27-20-11-18(8-5-15(20)2)24-19-9-10-30(14-17-6-7-17)21(19)12-22(28-24)29-25-26-13-16(3)32-25/h4-5,8-13,17H,1,6-7,14H2,2-3H3,(H,27,31)(H,26,28,29) |
| InChIKey | HHECSVZXCVOIND-UHFFFAOYSA-N |
| XLogP | 6.05 |
| TPSA | 71.84 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.58 |
| LogP ≤ 5 | 6.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172571755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.